Literature DB >> 9499303

[Epidemiologic study of injuries in childhood: the first pediatric trauma registry].

J A Navascués del Río1, J Soleto Martín, J Cerdá Berrocal, G Barrientos Fernández, R Luque Mialdea, C Estellés Vals, E de Tomás Palacios, J Vázquez Estévez.   

Abstract

OBJECTIVE: In order to collect and evaluate information concerning aspects of injuries in our pediatric population, we developed the first Spanish Pediatric Trauma Registry. PATIENTS AND METHODS: During 1995, 11,307 patients were seen at our hospital for acute injuries: 521 were admitted to the hospital and are included in our database. Each patient's protocol consists of 103 data points including: patient identification, type, place and mechanism of injury, prehospital care, transport, assessment on admission, severity scores, diagnostic studies, injuries, treatment and morbidity-mortality.
RESULTS: We found that accidents were more frequent in males (69) than in females. The predominant age group was 12-15 years (36%). Falls were the leading cause of injury (37%). A pediatric trauma score of 8 or less was seen in 13.4% of the cases. Twenty-nine patients were hospitalized in the Intensive Care Unit and 214 needed some surgical treatment.
CONCLUSIONS: The utility of this registry is: 1) The knowledge of the epidemiology of our pediatric population. 2) To know and correct prehospital care deficiencies. 3) To improve hospital assistance and to recognize early prognosis factors.

Entities:  

Mesh:

Year:  1997        PMID: 9499303

Source DB:  PubMed          Journal:  An Esp Pediatr        ISSN: 0302-4342


  2 in total

1.  Unintentional childhood injury mortality in Europe 1984-93: a report from the EURORISC Working Group.

Authors:  A Morrison; D H Stone
Journal:  Inj Prev       Date:  1999-09       Impact factor: 2.399

2.  Epidemiology, morbidity and mortality from fall-related injuries in the United Arab Emirates.

Authors:  Michal Grivna; Hani O Eid; Fikri M Abu-Zidan
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-09-02       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.